Organization Profile

You just read:

Sanofi Pasteur Announces Favorable Phase II Study Results for Investigational Clostridium difficile Vaccine at the American Society for Microbiology Meeting

News provided by

Sanofi Pasteur

May 19, 2014, 08:01 ET